Vimarsana
Biggest News Aggregation in the World

Human Factors Validation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Factors Validation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Factors Validation Today - Breaking & Trending Today

Implantica completes Human Factors Validation Study for RefluxStop™ as part of the US FDA Premarket Approval Process - Vimarsana News

Implantica completes Human Factors Validation Study for RefluxStop™ as part of the US FDA Premarket Approval Process

/PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces completion of the Human...

RiVive Nasal Spray Gets Priority Review for OTC Treatment of Opioid Overdose - Vimarsana News

RiVive Nasal Spray Gets Priority Review for OTC Treatment of Opioid Overdose

The FDA has accepted for Priority Review the NDA for RiVive (naloxone intranasal) as an over-the-counter emergency treatment for opioid overdose.

Fentanyl Overdose Antidote Gets Fast Tracked Review by FDA, Company Says - Vimarsana News

Fentanyl Overdose Antidote Gets Fast Tracked Review by FDA, Company Says

The U.S. Food and Drug Administration (FDA) will give priority status to an over-the-counter opium overdose antidote nasal ...

Harm Reduction Therapeutics' New Drug Application for RiVive™ Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA - Vimarsana News

Harm Reduction Therapeutics' New Drug Application for RiVive™ Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA

/PRNewswire/ -- Harm Reduction Therapeutics (HRT), Inc., a 501(c)(3) nonprofit pharmaceutical company whose mission is to prevent opioid overdose deaths by...

Harm Reduction Therapeutics' New Drug Application for RiVive™ Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA - Vimarsana News

Harm Reduction Therapeutics' New Drug Application for RiVive™ Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA

/PRNewswire/ -- Harm Reduction Therapeutics (HRT), Inc., a 501(c)(3) nonprofit pharmaceutical company whose mission is to prevent opioid overdose deaths by...